Innovative Trials Opens First US Office to Support Patient Access to Clinical Trials
Innovative Trials has opened its first international office in North Carolina in the US, signaling its commitment to accelerating patient access to life-changing treatments within North America. The company hopes to expand its operations in response to the growing business demand from global pharmaceutical companies. The expansion of the company is to move towards their goal for enabling patients to access new treatment options more quickly through clinical trials. The new office will enable them to provide greater operational and strategic flexibility for patient engagement and recruitment solutions fit clients’ needs and grow their workforce.
Read more about this news release here.
New machine-learning approach could speed precision drug development
The approach, detailed this week in the journal Nature, uses a platform called Molecular Surface Interaction Fingerprinting (MaSIF) to design custom proteins that bind to drug-bound target proteins.
AI-enabled CGM app shows promise for glycemic control, weight management
The broader implications of this study suggest that digital health platforms like January V2 have the potential to play a crucial role in the future of chronic disease management,” the authors write.
